Helix

Congratulations to our co-founder and CEO, James Lu, M.D. Ph.D, on being elected to the #ACMGFoundation Board of Directors! His leadership has been instrumental in driving precision health forward, and this recognition by ACMG - American College of Medical Genetics and Genomics is a testament to his impact on the field. “I am honored to join the ACMG Foundation Board and support its vital work in advancing the practice of medical genetics. At Helix, we’ve seen firsthand how large-scale genomic initiatives can transform patient care and population health. I look forward to supporting ACMG as it works toward expanding the reach of genomic medicine, bridging the gap between discovery and clinical adoption, and ensuring more patients benefit from the power of genetic insights,” said Dr. Lu. Read more here: https://hubs.ly/Q03d95m60 #Genomics #PrecisionHealth #HealthcareInnovation https://hubs.ly/Q03d96N10

Helix had an incredible time at #ACMGMtg25 this past week. Thank you to everyone who came by our booth, our talks and research posters. And for the highlight in the final symposium by Michael F. Murray. Couldn’t be prouder to be working with so many amazing health systems throughout the nation to build population screening programs that are making a genotype-first approach to patient care a reality. Renown Health, Mayo Clinic, MUSC Health, HealthPartners, Memorial Hermann Health System, WellSpan Health, St. Luke's University Health Network, Cone Health, Nebraska Medicine, Sanford Health, WakeMed, The Ohio State University, University Health Network, Parkview Health, TriHealth, Rochester Regional Health #genomics #precisionmedicine #populationhealth #medicalgenetics #genomicmedicine Thanks to our team onsite: James Lu, M.D. Ph.D, Cassie Hajek, MD FACP, FACMG, Dr Anwar A Chahal, Chad Haldeman-Englert, Raymond Kim, Angie Darnell, Hylton Kalvaria, Jaclyn Tan Eng, Alexandre Bolze, Kelly Schiabor Barrett, Matt Levy, Natalie Telis, Rachel Harvill, MPH https://lnkd.in/gv8PD4Qx

We’re at #ACMGMtg25 this week! Helix is excited to unveil new real-world research from the Helix Research Network, highlighting how genomics can improve risk identification, adherence to care, and precision medicine implementation for conditions like breast cancer and and Lynch Syndrome. Don’t miss our featured presentation at 12:30pm today with Matt Levy on improved clinical management following diagnosis with familial hypercholesterolemia in a population screening program. Meet our scientists at booth #440 at the ACMG reception to explore how #genomics is shaping the future of clinical care. https://bit.ly/43S955t #PrecisionMedicine #HealthcareInnovation #ClinicalGenetics

#IntheNews: In recognition of #AutoimmuneDisease Awareness Month, Helix is proud to announce the launch of a 23,000-patient clinico-genomic virtual registry—one of the largest in the world—to drive autoimmune disease research. By combining longitudinal clinical data with deep genomic insights from #exome sequencing, we aim to support life science researchers accelerate precision medicine development for the millions impacted by complex autoimmune conditions. Learn more about this transformative registry: https://bit.ly/41zadbG #PrecisionMedicine #Genomics #AutoimmuneResearch #DrugDiscovery #ClinicoGenomics #lupus #rheumatoidarthritis #ibd #multiplesclerosis

?? How does Semaglutide interact with your genes to impact weight loss? Discover insights driving precision medicine & drug discovery! ???? with Dr. Matt Levy & Jay Shah. ?? Watch now: https://bit.ly/4kQJKPm #Helix #GLP1 #PharmaDive #PrecisionMedicine #DrugDiscover

We're excited to be at #ACMGMtg25 in Los Angeles, CA from March 18-22! We'll be unveiling groundbreaking real-world insights from the Helix Research Network from our experts Alexandre Bolze, Kelly Schiabor Barrett, Cassie Hajek, MD FACP, FACMG, Rachel Harvill, MPH, Matt Levy and Natalie Telis, as well as our partners. Our analyses showcase how #genomics improves risk identification, care adherence and #precisionmedicine implementation to drive patient care forward. Check out our full list of posters and talks here: https://bit.ly/4iuWPME Come by and say hello at Booth #440! #HumanGenetics #Geneticsresearch #Genomics #Exome #PrecisionMedicine #DrugDiscovery #Research

#InTheNews: Our CEO James Lu, M.D. Ph.D recently sat down with Modern Healthcare to discuss how we're revolutionizing healthcare through population-scale genomics. Learn how Helix is partnering with leading health systems to: ?? Transform patient care through precision medicine ?? Drive innovative clinical research ?? Create sustainable, cost-effective solutions for patients ?? Power financial growth and sustainability for healthcare organizations Read the full interview: https://bit.ly/4jYBw7s #HealthcareInnovation #Genomics #PrecisionMedicine

#InTheNews: TriHealth shares more about the #populationhealth initiative they're launching with us, DNA Discovery with TriHealth, the largest program in Southwest Ohio that will provide greater #precision and #personalizedcare for patients. “Delivering a no cost, population genomics program to the Greater Cincinnati community will help tens of thousands of patients who choose to participate—and their providers--to better understand genetic predisposition to a number of diseases and to make more personalized health care decisions. This program is a fundamental step to being able to provide patients with more targeted, precision care.” said their President and CEO Mark C. Clement. Learn more here: https://bit.ly/3Ex8vj0

"...one size doesn't fit all, one size fits one person and that's why it's called precision medicine." ABC27 speaks to Dr. David Kann of WellSpan Health's Gene Health Project about how understanding your #genomics through a population-level program like theirs is the first step to getting #personalized healthcare. Check it out here: https://bit.ly/40XXTCq

#InTheNews: Helix has launched the world’s largest clinico-genomic virtual registry of over 15,000 patients treated with GLP-1 agonists—empowering researchers with real-world insights to optimize treatment efficacy, safety, and cost-effectiveness. Built as part of the Helix Research Network, this research-ready Virtual Registry enables a deeper understanding of how GLP-1s impact diverse patient populations, and advancing opportunities precision medicine development. Read more about this milestone here: https://bit.ly/40JSy0b #PrecisionMedicine #GLP1 #clinicogenomics #genomics #data #drugdiscovery